---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-018533"
form_type: "8-K"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2025-07-10T23:59:59+00:00"
generated_at: "2026-05-18T08:47:19.660684+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Tevogen Bio grants 8M restricted shares to CEO; total outstanding 193.7M shares

## Summary
- Board approved restricted stock awards on June 27, 2025, including 8M shares to CEO Dr. Ryan Saadi.
- Total outstanding shares now 193,693,433.
- CEO's shares vest in four equal annual installments starting on the seventh anniversary of grant.
- Other grantees' shares vest in three equal annual installments starting on the fifth anniversary.
- Shares subject to forfeiture if continuous service not maintained; cannot be transferred before vesting.

## SEC filing metadata
- accession: 0001641172-25-018533
- form_type: 8-K
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2025-07-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000164117225018533/0001641172-25-018533-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000164117225018533/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-018533
- JSON: https://secwatch.observer/filing/0001641172-25-018533.json
- Plain text: https://secwatch.observer/filing/0001641172-25-018533.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.